Therapeutic angiogenesis in ischemic heart disease.
Helisch
A
A
Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Ware
J A
JA
D000818:Animals; D003097:Collateral Circulation / Q000187:drug effects; D004195:Disease Models, Animal; D016228:Endothelial Growth Factors / Q000494:pharmacology / Q000627:therapeutic use*; D016220:Fibroblast Growth Factor 1; D016222:Fibroblast Growth Factor 2 / Q000627:therapeutic use; D051521:Fibroblast Growth Factor 5; D005346:Fibroblast Growth Factors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008222:Lymphokines / Q000494:pharmacology / Q000627:therapeutic use*; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000503:physiopathology*; D018919:Neovascularization, Physiologic / Q000187:drug effects; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; C496449:FGF5 protein, human; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D016222:Fibroblast Growth Factor 2; D016220:Fibroblast Growth Factor 1; D051521:Fibroblast Growth Factor 5; D005346:Fibroblast Growth Factors